2-methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells
2006 (English)In: Thyroid, ISSN 1050-7256, Vol. 16, no 2, 143-50 p.Article in journal (Refereed) Published
Anaplastic thyroid carcinoma (ATC) is one of the most malignant tumors in humans, and currently there is no effective treatment. In the present study we investigated the effect of an endogenous estrogen metabolite, 2-methoxyestradiol (2-ME), on the growth of human ATC cells. 2-ME treatment had a strong growth inhibitory effect on five human ATC cell lines (HTh7, HTh 74, HTh83, C643, and SW1736), but showed no effect on one cell line (KAT-4). Cell cycle analysis of the growth-inhibited cells showed that 2-ME induced a G2/M-arrest, followed by an increased fraction of cells in sub-G1. Analysis of internucleosomal DNA laddering as well as DNA fragmentation in a terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) assay demonstrated a high number of cells undergoing apoptosis after 2-ME treatment. An increased activation of caspase-3 and caspase-8 by 2-ME was observed, and inhibition of caspase-3 decreased the apoptotic effect. Addition of 2-ME increased activity of p38 mitogen-activated protein kinase (MAPK) in the sensitive HTh7 as well as the refractory KAT-4 cells, however, activation of stress-activated protein kinase/c-jun aminoterminal kinase (SAPK/JNK) was seen only in the HTh7 cells. Inhibitors of p38 MAPK and SAPK/JNK significantly attenuated the 2-ME effect. Taken together, our data demonstrate an antiproliferative and apoptotic effect of 2-ME on ATC cells involving activation of MAPKs.
Place, publisher, year, edition, pages
2006. Vol. 16, no 2, 143-50 p.
Antineoplastic Agents/pharmacology, Apoptosis, Blotting; Western, Carcinoma/*drug therapy/*metabolism/pathology, Caspases/metabolism, Cell Line; Tumor, DNA Fragmentation, Estradiol/*analogs & derivatives/pharmacology, Flow Cytometry, G1 Phase, Humans, In Situ Nick-End Labeling, MAP Kinase Signaling System, Models; Statistical, Osmosis, RNA; Messenger/metabolism, Research Support; Non-U.S. Gov't, Ribonucleases/metabolism, Thyroid Neoplasms/*drug therapy/*metabolism/pathology, Time Factors, p38 Mitogen-Activated Protein Kinases/metabolism
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-80918PubMedID: 16676399OAI: oai:DiVA.org:uu-80918DiVA: diva2:108832